NuVasive | NUVA - SCHULD



SCHULD Veränderung Datum
Abbott USD 13.86B 919M 2025-12
AtriCure USD 73.38M 3.35M 2025-12
Baxter International USD 9.78B 68M 2025-12
Becton, Dickinson and Co. USD 19.54B 358M 2025-12
Boston Scientific USD 11.44B 610M 2025-12
Cooper Companies USD 2.51B 27M 2025-09
Dexcom USD 1.24B 900K 2026-03
Edwards Lifesciences USD 600M 105.4M 2026-03
Globus Medical USD 118.66M 687K 2025-12
Haemonetics USD 1.22B 5K 2025-12
Inogen USD 0 0 2022-06
Insulet USD 949.2M 65.6M 2025-12
Integra LifeSciences USD 2.04B 6.27M 2026-03
Intuitive Surgical USD 0 0 2025-03
J&J USD 47.93B 2.14B 2025-12
Medtronic USD 28.07B 1.03B 2025-12
Merit Medical Systems USD 821.57M 420K 2025-12
Orthofix International USD 137.23M 338K 2024-09
Stryker USD 14.22B 635M 2026-03
Tandem Diabetes Care USD 444.48M 4.81M 2025-12
Teleflex USD 2.73B 43.5M 2025-12
Zimmer Biomet Holdings USD 7.47B 48.1M 2026-03